
zzso neurological syndromes zzso almost invariably zzso detection of the zzso zzso for zzso is important in zzso as the zzso directly affects prognosis and treatment and should be performed as soon as zzso 

an overview of the screening of zzso related to classical zzso is zzso Small cell lung cancer, zzso breast cancer, zzso zzso and zzso and zzso zzso are described in relation to zzso zzso encephalitis, zzso sensory zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso syndrome zzso zzso zzso and zzso peripheral nerve zzso 

many studies with class IV evidence were zzso one study reached level III zzso No evidence-based recommendations grade zzso were possible, but good practice points were agreed by zzso 

the nature of zzso and to a lesser extent the clinical syndrome, determines the risk and type of an underlying zzso For screening of the zzso region, a zzso is recommended, which if negative is followed by zzso zzso zzso zzso Breast cancer is screened for by zzso followed by zzso For the pelvic region, ultrasound zzso is the investigation of first choice followed by zzso zzso patients should have zzso US of the pelvic region and zzso in women, US of zzso in men under 50 years and zzso in men and women over zzso If primary screening is negative, repeat screening after 3-6 months and screen every 6 months up till 4 zzso In zzso screening for 2 years is zzso In syndromes where only a zzso of patients have a zzso zzso markers have additional value to predict a probable zzso 

